Cyclo Therapeutics, Inc. 8-K Report: Stock Insights & Updates (March 2023)

$CYTHW
Form 8-K
Filed on: 2023-03-20
Source
Cyclo Therapeutics, Inc. 8-K Report: Stock Insights & Updates (March 2023)

Here are the key insights extracted from the provided financial report section:

  1. Entity Information:
  • Company Name: Cyclo Therapeutics, Inc.
  • CIK Number: 0000922247
  • SEC File Number: 000-25466
  • IRS Employer Identification Number (EIN): 59-3029743
  • Address: 6714 NW 16th Street, Suite B, Gainesville, FL 32653
  • Phone Number: 386-418-8060
  1. Stock Information:
  • Common Stock: The par value of the common stock is $0.0001 per share.
  • Ticker Symbol: CYTH (Common Stock), CYTHW (Warrants to Purchase Common Stock)
  • Exchange: NASDAQ
  1. Reporting Period:
  • Report Date: March 20, 2023
  • The report covers a single day (March 20, 2023).
  1. Stock Categories and Custom Members:
  • The report includes classifications for different stock types:
    • Common Stock Par Value: $0.0001 per share.
    • Warrants to Purchase Common Stock.
  1. XML and XBRL Context:
  • The report utilizes XML and XBRL (eXtensible Business Reporting Language) for structuring financial information.
  • Relevant namespaces include US GAAP and custom dimensions for stock classification.
  1. Document Type:
  • This filing appears to be an 8-K form, which is used for reporting unscheduled material events or corporate changes.

Summary:

Cyclo Therapeutics, Inc. reported on March 20, 2023, concerning its common stock and warrants. The common stock has a par value of $0.0001 and is traded under the ticker symbol CYTH on NASDAQ, while warrants are under CYTHW. The report is structured using XBRL for better data management and reporting compliance.